FOSUN HEALTH Logo

Cerebral Haemorrhage Treatment

catalogue

Cerebral Haemorrhage Treatment

Cerebral Haemorrhage Treatment

The treatment of a cerebral haemorrhage is unlike the treatment of a blocked artery, and it is worth saying at the start that it contains no equivalent of the clot-dissolving drug. Nothing dissolves the blood that has already escaped, and nothing reliably restores the tissue it has destroyed. What can be changed is what happens next: whether the bleeding continues, what pressure the brain is under, and whether the fluid pathways inside the skull stay open. Almost all of that work happens in the first hours, and the decisions that matter are a small number of well-defined ones rather than a long list.

What the first hour is spent on

The first hour has a rhythm to it, and none of it is exotic. Airway, breathing and circulation come first, because a patient with reduced consciousness and an impaired swallow is at risk from the airway before anything else. Glucose is checked and corrected, since low glucose mimics and worsens a stroke. The CT is obtained without delay, and from that point the work divides into three strands that run at the same time.

The first strand is stopping the harm: any anticoagulant or antiplatelet drug is withheld immediately, and the specific one the patient takes is identified. The second is reducing the pressure that drives further bleeding, which in practice means blood pressure. The third is watching: neurological observations repeated at short intervals, because a change in the level of consciousness or in the weakness is the earliest and most reliable evidence that something has changed inside the skull, and it is acted on rather than observed.

Reversing an anticoagulant, and what is not reversed

Reversal is the most time-critical treatment in the whole condition, and the specific agent depends on the specific drug. Vitamin K with prothrombin complex concentrate is used for warfarin. Dabigatran has a targeted antidote. The factor Xa inhibitors are treated with a specific agent where it is available, or with concentrate where it is not. Heparin is reversed with protamine. Direct oral anticoagulants are not detected by an ordinary clotting screen, so a clear medication history matters as much as the laboratory result.

Two treatments that sound reasonable are not given routinely, and both rest on trial evidence rather than on preference. Recombinant activated factor VII reduces bleeding on imaging but has not been shown to improve how patients function, so it is not used as a routine measure. Platelet transfusion in a patient whose only antithrombotic is an antiplatelet drug was studied directly and found to do harm rather than good in spontaneous haemorrhage. Where a patient takes both an anticoagulant and an antiplatelet, the anticoagulant is the priority.

The other half of this question arrives weeks later rather than hours later: whether the anticoagulant can be restarted, and when. Pausing it protects the brain from further bleeding; leaving it stopped exposes the patient to the stroke or embolism it was prescribed to prevent. The balance depends on the reason it was prescribed, on whether the bleed was deep or lobar, and on how much the patient stands to lose either way — which is why it is decided by the teams that know both halves, deliberately, and revisited as things change.

Blood pressure: early, controlled, and not too far

High blood pressure is the strongest driver of further bleeding, and lowering it early is one of the few interventions in this condition with clear support. The practice that has emerged from trials is early intensive lowering to a systolic target in the region of 140 mmHg, achieved smoothly rather than abruptly, and with a floor: pressure is not driven low, because the brain around the bleeding still needs to be perfused.

The honest summary of the evidence is that this treatment is safer than was once feared and that its benefit on function is modest — the trials designed to show a clear functional gain did not show one, while they did show that rapid, substantial reductions in pressure do not cause the harm that was expected. That is why the target is a clinical judgement rather than a fixed number: it takes into account the patient's usual pressure, their age, whether the bleed is deep or lobar, and what their kidneys can tolerate.

When an operation helps, and when it does not

Fewer patients need surgery than most families expect, and the reasons are worth stating clearly because the alternative — that surgeons are being cautious — is the wrong explanation.

There is one situation in which the indication is well accepted: a cerebellar haemorrhage that is large enough to compress the brainstem or to obstruct the flow of cerebrospinal fluid. The space behind the brainstem is small, the consequences of pressure there are rapidly irreversible, and evacuation is performed. A patient who is deteriorating with hydrocephalus from a cerebellar bleed is operated on rather than watched.

For bleeding elsewhere in the brain, the position is more nuanced. Trials that compared routine surgical evacuation of a supratentorial haematoma with medical management did not show that operating on everyone helps, and trials offering surgery mainly to patients who were already deteriorating showed no clear overall benefit either. This does not mean surgery is never right — it means the decision is made for an individual patient on the basis of volume, location, the level of consciousness, how the patient is moving, and what is likely to be regained. Minimally invasive techniques for removing the clot, which are being refined and have shown encouraging results in selected lobar haemorrhages, are chosen for particular patients rather than applied routinely. Decompressive surgery — removing part of the skull to relieve pressure — is reserved for a small number of patients in whom swelling itself is the threat.

What a family should expect, therefore, is not a single answer but a reasoned position that may change. If the situation is one in which surgery is clearly indicated, it will be offered. If the situation is one in which the evidence is genuinely balanced, that will be explained rather than disguised, along with what would tip the decision.

Blood in the ventricles and the problem of blocked fluid

Blood that reaches the ventricles causes trouble out of proportion to its volume, because the ventricles are the channels through which cerebrospinal fluid circulates. When those channels block, fluid accumulates under pressure — hydrocephalus — and the patient deteriorates not from the bleed itself but from a problem that can be relieved mechanically.

The standard treatment is an external ventricular drain: a fine catheter placed into the ventricular system to divert cerebrospinal fluid, which both lowers the pressure and allows the fluid to be measured and sampled. It is a temporary measure, and it carries its own risks, chiefly infection and bleeding along the track, so it is used when the obstruction is significant and removed as soon as it is safe. Where blood in the ventricles is extensive, the drain may remain for a period and its management — how much fluid to drain, at what pressure, when to clamp it — becomes a substantial part of the daily care.

Clearing the blood from the ventricles has been studied directly, and the honest summary is that it can reduce the risk of dying without clearly improving how the survivors function. That is the kind of result that makes a treatment selective rather than routine, and it is one of the reasons the management of a haemorrhage with ventricular blood belongs in a centre that looks after enough of them to make these judgements well.

The days that follow: neurocritical care

The first week decides a great deal, and most of it is spent on things other than the clot. Intracranial pressure is watched and managed. Fever is treated rather than tolerated, because it worsens injured brain. Glucose is kept in range. Nutrition is established early, by tube if swallowing is unsafe. The patient is moved and positioned, and mechanical measures prevent clots in the legs until drug-based prevention can safely be considered. Swallowing is formally assessed before anything is given by mouth, because silent aspiration is common and its consequences are severe.

Monitoring continues in a stroke unit or neurocritical care setting rather than a general ward, because deterioration here is common, it happens early, and it is reversible when it is caught. Deterioration may mean that the haematoma has enlarged, that the ventricles have blocked, that the tissue around the clot is swelling, or that a seizure has occurred — four different problems with four different responses, which is precisely why the change itself is reported rather than interpreted.

This is also the period in which the question of prevention begins to take shape. Blood pressure treatment is adjusted and confirmed to be working. The cause is established from imaging and history, so that the prevention plan addresses the actual mechanism — pressure, amyloid angiopathy, or a structural lesion that needs its own treatment. And the conversation about any long-term blood thinner is set up with the people who prescribed it, rather than settled in passing.

Rehabilitation, and what recovery actually depends on

Most of the functional outcome after a cerebral haemorrhage is built in the weeks and months after the acute event, not in the first day, and this is the part of the illness in which patients and families have the greatest influence. Rehabilitation starts on the ward rather than after discharge: positioning, safe swallowing, sitting up, standing with support and the beginnings of task-based practice are begun as soon as they are safe, because the alternative — bed rest until strength returns — allows strength and coordination to fall instead.

The programme is matched to what has actually been lost, which varies with the site of the bleed. Weakness and balance need physical therapy; speech and language need their own assessment; swallowing needs a defined plan; attention, memory and mood need to be recognised rather than dismissed as a reaction to being ill. Spasticity — the increased tone that develops weeks later and can limit a recovering limb — is treated when it appears rather than when it has become fixed. Psychological support is part of the treatment and not an optional extra, since depression and anxiety after a stroke are both common and treatable.

Three things are worth saying plainly. Recovery is usually front-loaded — the largest gains come early — but improvement is recorded well beyond the first months, so a plateau at six weeks is not the end of the story. Progress depends more on whether the programme targets the specific impairments than on how long the programme is. And the part of prevention that is unambiguously effective is blood-pressure control, so that the treatment of the acute event and the prevention of the next one are the same conversation, started in the same hospital stay.

Frequently Asked Questions

Is there a drug that dissolves a brain haemorrhage?

No. The clot-dissolving drugs and the clot-retrieval procedures used for a blocked artery have no equivalent here — they are designed to open a blocked vessel and are dangerous when the vessel has already bled. What can be done is to stop the bleeding from continuing: blood pressure is brought down early, and any anticoagulant is reversed without delay. Removing the clot is sometimes helpful, but that is a surgical decision made for specific patients rather than a general treatment, and the blood that has already caused damage cannot be dissolved away.

Does everyone with a brain haemorrhage need surgery?

No — most patients do not. There is one situation where the indication is well accepted: a cerebellar haemorrhage large enough to compress the brainstem or to block the flow of cerebrospinal fluid, where evacuation is performed. Elsewhere the evidence is more balanced: trials comparing routine surgical evacuation with medical management have not shown a clear benefit for operating on everyone, and trials in patients who were already deteriorating showed no clear overall benefit either. Decisions are therefore made for individual patients, and minimally invasive techniques are chosen selectively. If the situation is genuinely balanced, it should be explained as balanced rather than presented as settled.

How quickly must an anticoagulant be reversed?

As quickly as it can be done safely, and the reversals are not interchangeable. Warfarin is reversed with vitamin K and prothrombin complex concentrate; dabigatran has a specific antidote; the factor Xa inhibitors are treated with a specific agent where available or with concentrate where it is not; heparin is reversed with protamine. One practical trap is that an ordinary clotting screen does not detect the direct oral anticoagulants, so the medication history matters as much as the laboratory result. Reversal is one of the few measures in this condition with a genuine deadline.

When can someone go home, and what happens then?

It depends on what has to be in place first: safe swallowing, control of blood pressure that is confirmed to be working, a plan for the impairments that remain, and a decision about any long-term blood thinner. Some patients go home directly, others to inpatient rehabilitation and then home. What follows is a programme rather than an appointment — physical therapy, speech and language work, and review of pressure treatment are usually continued for months, and much of it can be carried on locally with a written plan. Improvement is typically largest early and continues well beyond the first months, so the first review is a checkpoint rather than a verdict.

Bring the images and the medication list

Tell us what medication the patient takes — particularly any anticoagulant, its dose and when it was last taken — and what has been done so far. Send the CT and any further imaging with the reports, and note how the neurological state has changed since admission. A neurovascular specialist will return a written opinion within about 48 hours of complete records arriving: what the images show, whether the situation calls for surgery or for neurocritical care, how the risk of bleeding again should be weighed against the reason an anticoagulant was prescribed, and what the rehabilitation plan should target.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*